Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Madrigal Pharmaceuticals Inc (MDGL)

110.32   -3.67 (-3.22%) 06-03 16:00
Open: 113.58 Pre. Close: 113.99
High: 114.14 Low: 110.32
Volume: 93,909 Market Cap: 1,702M
Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 114.463 - 115.097 115.097 - 115.612
Low: 108.375 - 109.266 109.266 - 109.989
Close: 109.018 - 110.331 110.331 - 111.398

Technical analysis

as of: 2020-06-03 4:31:37 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 148.63     One year: 173.60
Support: Support1: 97.44    Support2: 79.01
Resistance: Resistance1: 127.25    Resistance2: 148.63
Pivot: 117.40
Moving Average: MA(5): 114.03     MA(20): 112.10
MA(100): 87.37     MA(250): 92.35
MACD: MACD(12,26): 6.90     Signal(9): 8.77
Stochastic oscillator: %K(14,3): 46.54     %D(3): 58.81
RSI: RSI(14): 54.34
52-week: High: 127.25  Low: 56.82  Change(%): 21.1
Average Vol(K): 3-Month: 23688  10-Days: 17689

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MDGL has closed above bottom band by 8.5%. Bollinger Bands are 22.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 07 May 2020
Madrigal Pharmaceuticals Reports 2020 First Quarter Financial Results and Highlights - GlobeNewswire

Sun, 10 May 2020
Was The Smart Money Right About Madrigal Pharmaceuticals (MDGL)? - Yahoo Finance

Mon, 11 May 2020
Oppenheimer Gives a Buy Rating to Madrigal Pharmaceuticals (MDGL) - Smarter Analyst

Thu, 28 May 2020
We Think Madrigal Pharmaceuticals (NASDAQ:MDGL) Can Afford To Drive Business Growth - Yahoo Finance

Tue, 05 May 2020
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Madrigal Pharmaceuticals, Inc. - MDGL - Yahoo Finance

Wed, 13 May 2020
Is A Downturn Overdue? Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), DiamondRock Hospitality Company (NYSE:DRH)? - State Reviewer

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15
Shares Float (M) 6
% Held by Insiders 10.80
% Held by Institutions 97.90
Shares Short (K) 3,390
Shares Short P. Month (K) 2,910

Stock Financials

EPS -6.810
EPS Est This Year -2.670
EPS Est Next Year -3.560
Book Value (p.s.) 24.980
Profit Margin
Operating Margin
Return on Assets (ttm) -16.1
Return on Equity (ttm) -24.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -7.430
Qtrly Earnings Growth
Operating Cash Flow (M) -66
Levered Free Cash Flow (M) -36

Stock Valuations

PE Ratio -16.20
PEG Ratio
Price to Book value 4.42
Price to Sales
Price to Cash Flow -25.93

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.